Moore Matthew Richard - Insider Non-Derivative Transactions at Arcutis Biotherapeutics, Inc. (ARQT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 2, 2024, Moore Matthew Richard's relationship to Arcutis Biotherapeutics, Inc. (ARQT) is Officer (SVP and Chief Business Officer), and currently has 145,505 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ARQT insiders.
Data Source: SEC.
Moore Matthew Richard - Insider Non-Derivative Transactions of ARQT Common Stock
Moore Matthew Richard - Insider Non-Derivative Transactions at ARQT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 3, 2024 | Sell -- (Common Stock) | 4681 | 8.74 | 145505 |
| May 2, 2024 | Acquisition -- (Common Stock) | 4166 | 0 | 150186 |
| Mar 5, 2024 | Sell -- (Common Stock) | 3468 | 11.12 | 146020 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 26666 | 0 | 81256 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 26666 | 0 | 107922 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 17650 | 0 | 125572 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 19750 | 0 | 145322 |
| Feb 14, 2024 | Acquisition -- (Common Stock) | 4166 | 0 | 149488 |
| Jan 13, 2024 | Acquisition -- (Common Stock) | 28000 | 0 | 54590 |
| Mar 3, 2023 | Sell -- (Common Stock) | 21 | 16.52 | 11690 |
| Mar 3, 2023 | Sell -- (Common Stock) | 1589 | 15.82 | 11711 |
| Mar 3, 2023 | Acquisition -- (Common Stock) | 14900 | 0 | 26590 |